CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY
CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY
复制标题
DOI：
10.4158/ep161392.cs
复制
发表时间：
2016-08-01
影响因子：
4.2
通讯作者：
Tamborlane, William
中科院分区：
文献类型：
--
作者：
Fonseca, Vivian A.;Grunberger, George;Tamborlane, William
目的/方法：持续血糖监测(CGM)的使用障碍继续阻碍这项有价值的糖尿病管理技术的采用。2016年2月20日，美国临床内分泌学家协会和美国内分泌学学会召开了一次公众共识会议，审查现有的CGM数据，并提出扩大CGM准入的策略。结果：与会者一致认为，证据支持CGM对1型糖尿病的好处，并且无论糖尿病类型，只要使用强化胰岛素治疗，这些好处可能都适用。CGM可能会减少急慢性并发症的医疗资源利用率，尽管需要现实世界的分析来确认潜在的成本节约和生活质量的改善。持续不断的技术进步提高了CGM的准确性和可用性，但需要在人为因素、数据传递、报告和解释方面进行更多创新，以促进更广泛的使用。在所有设备上使用类似指标开发标准化数据报告将促进临床医生和患者对CGM的理解和利用。结论：CGM可改善血糖控制，降低低血糖，并可能降低糖尿病治疗的总体成本。扩大CGM的覆盖面和利用率可能会改善糖尿病患者的健康状况。
Objective/Methods: Barriers to continuous glucose monitoring (CGM) use continue to hamper adoption of this valuable technology for the management of diabetes. The American Association of Clinical Endocrinologists and the American College of Endocrinology convened a public consensus conference February 20, 2016, to review available CGM data and propose strategies for expanding CGM access.Results: Conference participants agreed that evidence supports the benefits of CGM in type 1 diabetes and that these benefits are likely to apply whenever intensive insulin therapy is used, regardless of diabetes type. CGM is likely to reduce healthcare resource utilization for acute and chronic complications, although real-world analyses are needed to confirm potential cost savings and quality of life improvements. Ongoing technological advances have improved CGM accuracy and usability, but more innovations in human factors, data delivery, reporting, and interpretation are needed to foster expanded use. The development of a standardized data report using similar metrics across all devices would facilitate clinician and patient understanding and utilization of CGM. Expanded CGM coverage by government and private payers is an urgent need.Conclusion: CGM improves glycemic control, reduces hypoglycemia, and may reduce overall costs of diabetes management. Expanding CGM coverage and utilization is likely to improve the health outcomes of people with diabetes.